Kentucky’s Opioid Abatement Advisory Commission (KYOAAC) held the second of two public hearings and general information sessions regarding its plan to allocate $42 million from state funds for ibogaine research to support the treatment of addictions and to help stem opioid overdoses.
On Friday, Sept. 15, the commission heard over two dozen military veterans, former patients, parents and family members, psychologists and other advocates for treating Opioid Use Disorder (OUD) with the naturally-occurring psychedelics. The shared their insights and hopes, following the first hearing (on July 17) which featured scientific experts and clinicians.
See Also: Psychedelics To Treat Addiction? How Substances Like Ibogaine Are Changing The Game
KYOAAC is …